| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/11/1997 | EP0656786A4 Health supplements containing phyto-oestrogens, analogues or metabolites thereof. |
| 06/11/1997 | EP0525005B1 Method for inhibiting cell growth and compositions useful therefor |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | CN1151740A 7-ether-taxol analogs, antineoplastic use and pharmaceutical compsns. containing them |
| 06/11/1997 | CN1151701A Cascade-polymer complexes and method of producing the same |
| 06/11/1997 | CN1151315A Anti-cancer capsule |
| 06/11/1997 | CN1151292A Medicinal preparation for treatment of tumour |
| 06/10/1997 | US5637723 Esterification of baccatine; deblocking |
| 06/10/1997 | US5637703 Derivatives of genistein |
| 06/10/1997 | US5637619 Antitumor 2-aminocarbonyl-1, 2-bis(methylsulfonyl)-1-(substituted)hydrazines |
| 06/10/1997 | US5637608 Photodynamic therapy |
| 06/10/1997 | US5637605 α-fluoro-α-1-(1,2,4-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors |
| 06/10/1997 | US5637590 Rapamycin amidino carbamates |
| 06/10/1997 | US5637581 Preparations containing 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines |
| 06/10/1997 | US5637577 Treatment of potozoal diseases |
| 06/10/1997 | US5637572 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 06/10/1997 | US5637569 Ganglioside analogs |
| 06/10/1997 | US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 06/05/1997 | WO1997020060A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | WO1997020047A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | WO1997019954A1 Targeted cytotoxic anthracycline analogs |
| 06/05/1997 | WO1997019953A2 New lh-rh antagonists with improved effectiveness |
| 06/05/1997 | WO1997019946A1 Pyridopyrimidines |
| 06/05/1997 | WO1997019914A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 06/05/1997 | WO1997019724A1 Hollow-tube brachytherapy device |
| 06/05/1997 | WO1997013776A3 Novel amine derivatives of epipodophyllotoxin 2', 3'-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer |
| 06/05/1997 | DE19544686A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/05/1997 | DE19544212A1 Neue LH-RH-Antagonisten mit verbesserter Wirkung New LH-RH antagonists with improved activity |
| 06/05/1997 | CA2238829A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | CA2238647A1 Hollow-tube brachytherapy device |
| 06/05/1997 | CA2238570A1 New lh-rh antagonists with improved effectiveness |
| 06/05/1997 | CA2236868A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776899A1 Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/04/1997 | EP0776885A1 Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses |
| 06/04/1997 | EP0776881A1 Bi-aromatic compounds comprising an adamantyl group in para-position, pharmaceutical and cosmetic compositions containing them and their utilization |
| 06/04/1997 | EP0776365A2 Retinoblastoma protein-interacting zinc finger proteins |
| 06/04/1997 | EP0776338A1 Immunoconjugates comprising tyrosine kinase inhibitors |
| 06/04/1997 | EP0776333A1 Peptide antagonist intermediates of neurotensin |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776328A1 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them |
| 06/04/1997 | EP0776324A1 Endothelin antagonists |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0776161A1 A method of selectively destroying neoplastic cells |
| 06/04/1997 | EP0691980B1 7-deazapurine modified oligonucleotides |
| 06/04/1997 | EP0672119A4 Retroviral mediated transfer of the human multiple drug resistance gene. |
| 06/04/1997 | EP0559690B1 8-ENE-19, 11 beta-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM |
| 06/04/1997 | EP0527802B1 Ligand for the neu gene product |
| 06/04/1997 | CN1151186A Thymidine kinase mutants |
| 06/04/1997 | CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 06/04/1997 | CN1151157A Metalloproteinase inhibitors |
| 06/04/1997 | CN1151156A Isoprenyl transferase inhibitors |
| 06/04/1997 | CN1151154A Novel antitumor and antileukemia substanes, preparation thereof and pharmaceutical compositions containing same |
| 06/04/1997 | CN1151120A Method and compositions useful for inhibition of angiogenesis |
| 06/04/1997 | CN1151119A Medical use of bromelain |
| 06/04/1997 | CN1151117A Binding of E-selectin, P-selectin or L-selectin to sialyl-Lewis(x) or sialyl-lewis(a) |
| 06/04/1997 | CN1150947A Alkenyl-benzoyl guanidine derivant |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/04/1997 | CN1035055C Process for preparaing unsaturated 17-'beta' substituted 3-carboxysteroids |
| 06/03/1997 | USRE35524 Antitumor agents |
| 06/03/1997 | US5635533 Antitumor agents |
| 06/03/1997 | US5635532 Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
| 06/03/1997 | US5635515 Administering cinchonine and/or hydroquinidine |
| 06/03/1997 | US5635483 Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| 06/03/1997 | US5635399 Retroviral vectors expressing cytokines |
| 05/29/1997 | WO1997019194A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 05/29/1997 | WO1997019111A2 Monoclonal antibodies anti-cd6 and their uses |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997019097A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | WO1997019086A1 Epothilone derivatives, preparation and use |
| 05/29/1997 | WO1997019081A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/29/1997 | WO1997019080A1 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides |
| 05/29/1997 | WO1997019064A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |
| 05/29/1997 | WO1997019058A1 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols |
| 05/29/1997 | WO1997019053A1 Metalloproteinase inhibitors |
| 05/29/1997 | WO1997019052A1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997018819A1 Antineoplastic methods and compositions employing optically pure (-)-fotemustine |
| 05/29/1997 | WO1997018818A1 Antineoplastic methods and compositions employing (+)-fotemustine |
| 05/29/1997 | WO1997018816A2 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 05/29/1997 | WO1997018813A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | WO1997013505A3 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 05/29/1997 | WO1997009343A3 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238290A1 Methods for determining compounds capable of inhibiting the activities of the ha-ras oncogene |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | CA2238081A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | CA2237909A1 Antineoplastic methods and compositions employing (+)-fotemustine |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2237695A1 Antineoplastic methods and compositions employing optically pure (-)-fotemustine |
| 05/29/1997 | CA2236825A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses |
| 05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
| 05/28/1997 | EP0775488A1 Stable pharmaceutical composition on the basis of acetylsalicyclic acid and tocopherol |